Notice: This company has been marked as potentially delisted and may not be actively trading. Pear Therapeutics (PEAR) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Rachel Reeves tries cell sorting experiments at Quell TherapeuticsNovember 14, 2024 | msn.com49 US startups have become unicorns so far in 2024: Here’s the full listOctober 25, 2024 | techcrunch.comVibes for digital health deals improve after slumpOctober 22, 2024 | msn.comPursueCare Introduces RESET® and RESET-O®—FDA-Authorized Digital Therapeutics for Addiction TreatmentOctober 16, 2024 | finance.yahoo.comAvalyn CEO Lyn Baranowski Named a PharmaVoice 100 HonoreeOctober 8, 2024 | finance.yahoo.comNew York tech investor and serial entrepreneur Kevin Ryan explains when to sell your companySeptember 29, 2024 | msn.comGeorge Church spinout gets $65M to ‘revolutionize’ cell therapySeptember 19, 2024 | bizjournals.comMore than 90 business leaders endorse Kamala Harris for presidentSeptember 8, 2024 | msn.comSaks Fifth Avenue’s New High Jewelry Line Is Full of Serious Heavyweight DiamondsAugust 30, 2024 | yahoo.comSaks Fifth Avenue's New High Jewelry Line Is Full of Serious Heavyweight DiamondsAugust 29, 2024 | msn.comSaks Fifth Avenue Introduces High Jewelry CollectionAugust 27, 2024 | msn.comFrankfort Avenue El Mundo location for sale after owners cite COVID-19 troublesAugust 7, 2024 | msn.com32 of the most venomous animals in the worldAugust 6, 2024 | msn.com38 startups have become unicorns so far in 2024: Here’s the full listAugust 6, 2024 | techcrunch.comForesight Diagnostics Expands Series B Financing to $73.75 Million to Advance the Foresight CLARITY™ MRD PlatformJuly 30, 2024 | finance.yahoo.comHighmark Blue Cross Blue Shield Welcomes Workers to New Seneca One Tower HomeJuly 26, 2024 | msn.comForbes Daily: Big Tech Stocks Flail In Evidence Of Market RepositioningJuly 20, 2024 | forbes.comSapreme Appoints CEO, BoD Chair and SAB to Advance Development of Next-Generation RNA Therapeutics for Genetically Driven DiseasesMay 28, 2024 | finance.yahoo.comPear Therapeutics (PEARQ) Earnings Dates & ReportsMay 22, 2024 | investing.comAcorda: Q1 Earnings SnapshotMay 14, 2024 | sfgate.comWork on Highway 99 northbound lanes near Avenue 12 beginsApril 18, 2024 | yahoo.comExclusive: AlleyCorp raises a $250 million fund, taking on external investors for the first timeApril 9, 2024 | msn.comFDA approves first prescription-only app for depressionApril 5, 2024 | msn.comAcorda Therapeutics and Merz Announce Signing of "Stalking Horse" Asset Purchase AgreementApril 1, 2024 | finance.yahoo.comAcorda Therapeutics Files for Bankruptcy ProtectionApril 1, 2024 | wsj.comVirtual Clinic Pelago Is Reimagining Rehab With $58 Million In New FundingMarch 28, 2024 | forbes.comGirl's rare disease inspired new drug model. Now the drug trial has hit a pivotal pointMarch 19, 2024 | bizjournals.comBetter Therapeutics lays off staff, considers winding down businessMarch 15, 2024 | finance.yahoo.comBratu named marketing and development director for State GamesMarch 14, 2024 | finance.yahoo.comBetter Therapeutics wins breakthrough status for health app to treat liver diseaseFebruary 21, 2024 | finance.yahoo.comGlobal Internet Addiction Disorder Market Size Is Expected To Hold a Significant Share By 2033 | CAGR of 11.45%January 31, 2024 | finance.yahoo.comSmart Pills Market Set to Soar Past USD 12.39 billion by 2030January 31, 2024 | finance.yahoo.comHow Pharma Can Borrow A Page From Digital Health Investors’ PlaybookJanuary 31, 2024 | forbes.comCognito Therapeutics raises $35M for neuro deviceJanuary 31, 2024 | axios.comHealthcare bankruptcies reached five-year peak in 2023, report findsJanuary 26, 2024 | finance.yahoo.comAcorda Therapeutics to Regain Global Commercialization Rights to FAMPYRA® by January 2025January 11, 2024 | finance.yahoo.comDigital Therapeutics Global Market to Observe Stunning Growth at a CAGR of ~28% by 2028 | DelveInsightDecember 20, 2023 | finance.yahoo.comPear Therapeutics Inc Class A PEARQNovember 11, 2023 | morningstar.comNox Health Appoints Frances Thorndike, Ph.D. to lead Medical & Scientific AffairsNovember 9, 2023 | finance.yahoo.comPEARQ Pear Therapeutics, Inc.October 27, 2023 | seekingalpha.comDigital Therapeutics Market Is Projected to Gain $22.60 Billion By 2031, Growing at a 19.4% CAGR: Allied Market ResearchOctober 24, 2023 | benzinga.comDeals of the Year: Somryst 'literally completes our portfolio,' Nox Health CEO saysOctober 18, 2023 | bizjournals.comBiotech's 2023 ghosts haunt efforts to exorcise downturnOctober 10, 2023 | bizjournals.comMigraine Pipeline, Clinical Trials, Emerging Therapies and FDA Approvals 2023 (Updated)September 28, 2023 | benzinga.comPear Therapeutics, Inc. (PEARQ)September 25, 2023 | finance.yahoo.comADHD video game maker Akili shifts focus from prescription to OTC, lays off 40%September 14, 2023 | axios.comDigital health startup Akili cuts staff by 40%, abandons prescription modelSeptember 13, 2023 | bizjournals.comShaping the Future of Medicine: Anticipated $17.7 Billion Digital Therapeutics Market by 2027August 28, 2023 | benzinga.comFormer execs from defunct Pear Therapeutics start VC firmAugust 23, 2023 | msn.comStartups Struggle With Insurers Over Digital TreatmentsJuly 27, 2023 | msn.com Get Pear Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter. Email Address PEAR Media Mentions By Week PEAR Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PEAR News Sentiment▼0.000.70▲Average Medical News Sentiment PEAR News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PEAR Articles This Week▼00▲PEAR Articles Average Week Get Pear Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PEAR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies KDLY News ATPC News VSEE News BTTX News LFST News PRVA News WGS News USPH News PNTG News TALK News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PEAR) was last updated on 1/31/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored#1 Crypto of 2025Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe crypto bull market is here, and the stakes couldn’t be higher. The next 3-6 months? They’re the most ex...Crypto Swap Profits | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pear Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pear Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PEAR Stock Alerts